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Abstract
Objectives: To describe the prevalence of the metabolic syndrome (MetS) among older persons in rural Bangladesh, to
investigate whether the prevalence varies by age, sex, literacy, marital status, nutritional status and socio-economic status,
and to assess the impact of MetS on survival.
Methods: The study consisted of 456 persons who were aged $60 years living in a rural area of Bangladesh during July
2003–March 2004. Data were collected through interview, clinical examination, and laboratory tests, and their survival status
until 30
th June 2009 was ascertained through the Matlab surveillance system. We defined MetS following the NCEP ATP III
criteria, with minor modifications, i.e., presence of any three of the following: hypertension (BP $130/85 mm Hg); random
blood glucose (RBG) level $7.0 mmol/L; hyper-triglyceridemia ($2.28 mmol/L); low level of HDL-cholesterol (,1.04 mmol/L
for men and ,1.29 mmol/L for women); and BMI $25.0 kg/m
2. Data were analysed with logistic regressions for the
influential factors of MetS, and with Cox models for the association of MetS with the survival status.
Findings: The overall prevalence of MetS was 19.5%, 20.8% in women, and 18.0% in men. Asset-index and nutritional status
were independently associated with MetS. During 4.93 years of follow-up, 18.2% died. In the presence of high RBG, MetS has
a significant negative effect on survival (69.4% vs 95.2%, log rank p=0.02).
Conclusion: This study highlights the importance of the metabolic syndrome in rural Bangladesh. Our findings suggest that
there is a need for screening programmes involving the metabolic syndrome to prevent diabetes and cardiovascular
diseases.
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Introduction
The metabolic syndrome (MetS) is a constellation of obesity,
hyperglycaemia, decreased high density lipoprotein (HDL), in-
creased triglyceride, and high blood pressure [1]. The MetS, as a
driver of current epidemics of diabetes [2] and cardiovascular
diseases (CVD) [3], has become a major challenge to public health
around the world. The association of MetS with myocardial
infarction (MI), stroke, and diabetes, has been extensively docu-
mented [4] and CVD is the major cause of death in the developing
world [5]. Importantly, about 80% of the global burden of CVD
related death occurs in low- and middle-income countries [6].
World-wide, the prevalence of MetS ranges from 10% to 50%
[7]. The detection, prevention, and treatment of the MetS
components should become an important approach for the
reduction of the cardiovascular disease burden in the general
population [8]. Hence, the identification of the population at risk is
of utmost importance.
In recent years, several studies [9–15] have shown the
increasing importance of MetS in low-income countries, but few
studies have focused on rural populations. In this population-based
study of persons aged 60 years and above living in rural
Bangladesh, we seek (1) to determine the prevalence of MetS, (2)
to examine factors related to MetS, and (3) to assess the impact of
MetS on survival.
Methods
Participants
Study participants were from the ‘‘Poverty and Health in
Ageing’’, a collaborative project between Ageing Research Centre
at Karolinska Institutet, Sweden and ICDDR,B, Bangladesh. This
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15is a cross-sectional study of elderly persons aged 60 years or more,
conducted in Matlab, a rural sub-district of Bangladesh. Since
1966, icddr,b has maintained a Health and Demographic
Surveillance System (HDSS) in this area which is divided into
seven blocks and covers a population of approximately 220,000
across 142 villages, where regular update of all vital events is
maintained. For this study, we selected two blocks, which are
nearest to the main Matlab hospital.
Ethics Statement
Ethical approval was received from both Karolinska Institutet,
Sweden and Institutional Review Board (IRB) ICDDR,B
Bangladesh. Information about the study was provided to and
informed consent was obtained from all participants.
Of the 850 randomly selected older persons from the two
purposively selected blocks, 63 died before data collection, 38
refused to participate, 11 migrated, 93 could not be reached, 18
were registered twice in the surveillance database, and 2 persons
were found to be under 60 years of age. Thus, 625 respondents
were interviewed in their homes, of whom 473 participated in the
clinical examination. Complete information for the current study
was available for 456 persons, slightly more than 50% of the
original sample. The non-participants (n=169) were more likely to
be women, older and with poor socio-economic status, but their
health profile did not differ from the respondents [16].
Data collection
Between July 2003 and March 2004, data were collected in two
sessions on two separate days. Data on demographics, socio-
economic status, and self-reported morbidity were collected during
a home interview by trained interviewers. Clinical examinations
were conducted at the local ICDDR,B health centre by physicians
and blood samples were taken for laboratory analyses.
Definition of the metabolic syndrome
We define the MetS following the criteria proposed by the
Third Report of the National Cholesterol Education Program
Expert Panel on the Detection, Evaluation, and Treatment of
High Blood Cholesterol in Adults (NCEP ATP III) [17]. The
NCEP ATP III criteria comprise 3 or more of the following: (1)
fasting plasma glucose level of at least 110 mg/dL (6.1 mmol/L);
(2) serum triglyceride level of at least 150 mg/dL (1.7 mmol/l) for
men; (3) serum high-density lipoprotein (HDL) cholesterol level
lower than 40 mg/dL (1.04 mmol/L) for men and lower than
50 mg/dL (1.29 mmol/L) for women; (4) Blood Pressure of at
least 130/85 mm Hg or controlled with antihypertensive treat-
ment; and/or (5) waist circumference of more than 102 cm (Adult
Treatment Plan III 2001). The NCEP ATP III definition does not
specify that any particular component be present and implies that
if a person has several risk factors, even if they are not very severe,
their joint contribution can still markedly increase the risk of
coronary heart disease.
In this study, the MetS is defined as having any 3 of the
following: 1) high blood glucose $7.0 mmol/L; 2) hypertriglyc-
eridemia (triglyceride level $2.28 mmol/L); 3) low level of HDL
cholesterol (,1.04 mmol/L for men and ,1.29 mmol/L for
women); 4) BMI $25.0 kg/m
2and 5) hypertension (systolic BP
$130 mm Hg or diastolic BP $85 mm Hg).
We used non-fasting blood sample for biochemical analysis
because it was not possible to request the fasting state of the elderly
people. Further we used a cut-off $200 mg/dL ($2.28 mmol/L)
to define high triglyceride, which is in line with other studies [18].
Literacy was defined as the ability to read and write in Bangla
language. Asset index is used as proxy for socio-economic status of
the respondents. Asset index data was collected separately from
the surveillance database of HDSS of ICDDR,B. The asset index
is based on household assets and housing characteristics, including
such as bed, mattress, quilt, cooking pots, watch, chair, clothing
cabinet, radio, television, bicycle, boat, cows and electricity. Using
a variable reduction technique, these assets and characteristics
were combined into a single variable. After ranking this variable
from low to high, households were divided into 3 equally sized
groups, the poverty tertiles. Details about the calculation of the
asset index can be found elsewhere [19]. Marital status was
categorized as married or single. Divorced, widows, widowers and
never married persons were included in the single group, and the
category married represents currently married persons. Nutritional
status was assessed using the Mini Nutritional Assessment (MNA)
[20]. The calculation of the nutritional status has been described in
detail previously [16]. For this study we grouped the ‘undernour-
ished’ and ‘at risk of malnutrition’ into ‘not well-nourished’.
Height and weight were measured with the participant barefoot
and lightly dressed. Body mass index was calculated as weight (kg)
divided by height squared (m
2). Blood pressure was measured by
sphygmomanometer, after taking a 5-min rest, and with standard
procedure. The sitting-position measurements were used in this
study. Plasma lipids (high-density lipoprotein [HDL] cholesterol
and triglycerides) and glucose were measured using standard
enzymatic methods. Random blood glucose was measured by an
ACCU-CHECK glucometer.
Mortality data
Data on survival status of all participants until 30
th June 2009
are from the routine surveillance program of HDSU of ICDDR,B,
in which ICD-10 is used to clarify the cause of death (ICD-10,
WHO).
Data analyses
Descriptive analyses included mean and standard deviations
(SD) for continuous variables. Prevalence and frequencies are
expressed in terms of percentage. Categorical variables were
compared by chi-square statistic. Logistic regression was used to
examine factors related to MetS. Kaplan-Meyer survival analysis
was used to examine the relationship of MetS, as well as its various
components, with survival up to five years. Also, Cox model was
applied for estimating the hazard ratio for mortality by MetS. All
analyses were performed using the statistical software SPSS
Statistics version 11.5 for Windows.
Results
Table 1 presents the characteristics of study participants, The
mean age of the 456 participants was 69 years (SD 6.8; range 60–
92), and 55% were female.
The prevalence of low HDL was 98.2%, in combination with
the other components, this leaves only 0.4% (two individuals)
without any MetS risk component. All five risk components were
present in 0.9% of the participants (data not shown), and high
blood pressure was prevalent 49.8% (Table 2). The prevalence of
the MetS components did not differ significantly between men and
women, except high triglycerides where women had a higher
prevalence than men (p=0.005) (Table 2). The overall prevalence
of MetS was 19.5%, slightly higher prevalence in women (20.8%)
compared to men (18.0%) (p=0.26) (Table 3). The prevalence of
MetS did not change consistently with increasing age (Table 3).
Asset index and nutritional status were found to be indepen-
dently associated with MetS (Table 4).
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4.93 years. During this time period 14 (3.1%) left the study area
and were considered lost to follow up. Analyses of the survival
status of this population suggested that those with MetS had a
slightly lower survival rate (78.8%) compared to those without
MetS (81.8%). This difference was however not statistically
significant (log rank p=0.55, df=1) (Figure 1). Cox regression
analyses suggested that the hazard ratio of death related to MetS
was 1.17 (95% CI 0.70–1.98). The major cause of death in this
sample was circulatory system related (61.4%); cerebro-vascular
diseases being the most prevalent cause followed by ischemic heart
disease and then hypertensive diseases. Deaths due to the
circulatory system constituted 66.7% of the total number of
deaths in the MetS group and 60% of the deaths in the non MetS
group (not statistically significant).
In further analysis, we found that, in the presence of high RBG,
MetS has a significant negative effect on survival (69.4% vs 95.2%,
log rank p=0.02, df=1). Survival with the other individual
components triglyceride, high blood pressure and high BMI did
not reveal any significant differences (Figure 2).
Discussion
In this study we have found the overall prevalence of MetS was
19.5%, 20.8% in women, and 18.0% in men. Asset-index and
nutritional status were independently associated with MetS.
During 4.93 years of follow-up, 18.2% died. Cox regression
analysis suggested that the hazard ratio of death related to MetS
was 1.17 (95% CI 0.70–1.98). In the presence of high RBG, MetS
has a significant negative effect on survival (69.4% vs 95.2%, log
rank p=0.02)
This study was based on a random sample of elderly individuals
living in the community in Matlab, a rural area of Bangladesh.
The prevalence of MetS was 19.5%, consistent with findings from
other studies, e.g., the Botnia study in Finland and Sweden 22.6%
[21] and 12% in the Risk Factors and Life Expectancy Study
(RIFLE) study in Italy [22]. Recent studies from developing
countries reported various prevalence rates depending on the
criteria used in defining the MetS. In Iran, using the NCEP
criteria, prevalence of MetS was estimated to be between 24% and
30%, depending on sex [23]. In India, 25% of subjects had the
MetS by IDF criteria [24], another study reported the prevalence
by NCEP criteria as 9.3% in rural central India [25]. In
Seychelles, an island country of African region, according to the
ATP, WHO and IDF definitions, the prevalence of MetS was,
respectively, 24.0%, 25.0%, 25.1% in men and 32.2%, 24.6%,
35.4% in women [26]. In the semi-rural areas of Turkey the
prevalence of MetS was 27.6% by NCEP criteria [27]. There is a
scarcity of data regarding the prevalence of MetS in Bangladesh.
However, in a study conducted amongst rural Bangladeshi women
($18 years), the prevalence was low (,3%) [28]. Another
prevalence study conducted on clinic based hypertensive patients
(20–79 years) found prevalence of 64% [29]. This is the first
population based data regarding prevalence of MetS among older
persons of rural Bangladesh. This study underscores the
importance of metabolic syndrome in rural Bangladesh as one in
every five elderly subjects is affected by the syndrome. In our study
we have found a slightly higher, although not significant,
prevalence rate of MetS among the women, similar to some
studies [30,22] and contrary to other [21].
The prevalence of high blood pressure was 50% and 49%
among women and men respectively, which is a finding similar to
figures reported in other studies [21,31]. We have found a very
high prevalence of low HDL cholesterol in this population
(98.2%). Evidence exists that Asian Indians have low HDL
[32,33], and the level of HDL 2b, the most protective component
of HDL is low in .90% of Asian Indians [34]. In a Bangladeshi
sample of hypertensive women aged 20–79 years, the prevalence
of low HDL cholesterol was more than 90% [29]. Another study
conducted on Bangladeshi rural women aged 18 years and above
reported the prevalence of low HDL cholesterol as 65% [28].
Among the South Asians, the prevalence of low HDL is higher
Table 1. Characteristics of the study population (n=456) by
status of the metabolic syndrome.
Characteristics
Number of
subjects, n (%) The metabolic syndrome
Present Absent p-value
Age group, years
60–69 273 (59.9) 56 (62.9) 217 (59.1)
70+ 183 (40.1) 33 (37.1) 150 (40.9) 0.298
Sex
Men 206 (45.2) 37 (41.6) 169 (46.0)
Women 250 (54.8) 52 (58.4) 198 (54.0) 0.261
Literacy
Illiterate 272 (60.0) 48 (54.5) 224 (61.4)
Literate 181 (40.0) 40 (45.5) 141 (38.6) 0.146
Marital status
Single 194 (42.5) 38 (42.7) 156 (42.5)
Married 262 (57.5) 51 (57.3) 211 (57.5) 0.533
Asset Index
Lowest tertile 143 (33.1) 14 (16.7) 129 (37.1)
Middle tertile 145 (33.6) 37 (44.0) 108 (31.0)
Highest tertile 144 (33.3) 33 (39.3) 111 (31.9) 0.001
Smoking
No 272 (59.8) 60 (67.4) 212 (57.9)
Yes 183 (40.2) 29 (32.6) 154 (42.1) 0.064
Tobacco leaf
No 134 (30.4) 32 (37.2) 102 (28.7)
Yes 307 (69.6) 54 (62.8) 253 (71.3) 0.082
Nutritional status
Not well nourished 388 (87.6) 63 (74.1) 325 (90.8)
Well nourished 55 (12.4) 22 (25.9) 33 (9.2) ,0.001
doi:10.1371/journal.pone.0020259.t001
Table 2. Prevalence of different components of the
metabolic syndrome by sex.
Components Total, n (%) Men, n (%) Women, n (%) p-value*
Low HDL 448 (98.2) 204 (99.0) 244 (97.6) 0.215
High blood pressure 227 (49.8) 102 (49.5) 125 (50.0) 0.496
High Random blood
glucose
60 (13.2) 25 (12.1) 35 (14.0) 0.329
High triglyceride 89 (19.5) 29 (14.1) 60 (24.0) 0.005
High BMI 24 (5.3%) 7 (3.4) 17 (6.8) 0.078
*p-value is for comparison between men and women.
doi:10.1371/journal.pone.0020259.t002
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the Pakistanis (30%) and three times higher than that of the
Indians (17%). In an African sample, the prevalence of
dyslipidemia (TG .150 mg% or HDL cholesterol ,40 mg%)
was 92% among the persons with MetS [31].
In studying the determinants, we found that nutritional status
and asset index were significantly associated with MetS. The
absence of significant differences by age groups is contrasting
prevalence studies performed in the west [22,35]. A likely reason is
that people in Bangladesh with this syndrome develop coronary
heart diseases and die at a younger age. Furthermore, it is evident
that people from this region (South East Asia) are prone to
developing CHD at a younger age, often before the age of 40 years
[36].
The interesting relationship between socioeconomic status and
MetS is sometimes mediated by behavioural factors, which are
related to both MetS, and to socioeconomic status [37]. Contrary
to some [38–40], but in line with others [41], we didn’t find any
association between smoking and MetS, neither between the use of
tobacco leaf and MetS. Indeed, smoking tends to be associated
with a decreased odds ratio of MetS. Because this analysis is based
on cross-sectional data, it is likely that survival bias may, at least
partly, account for the result, especially when both smoking and
MetS were associated with high mortality. We found instead
independent relationships of MetS with socioeconomic status,
assessed by asset index; the respondents belonged to the middle
and the highest tertiles are at significantly higher risk of having
MetS, compared to the lowest, hence the poorest one third of the
respondents. Factors associated with this relationship appear to be,
paradoxically, things which many people would regard as
improvements in their lives. They include higher consumption of
meat; the respondents who belonged to the highest tertile were
approximately four times more likely to consume meat daily
compared to the people who belonged to the lowest, hence the
poorest tertile in this study population, and milk consumption
increased from 47% among the lowest tertile to 69% among the
respondents belonged to the highest tertile. Well nourished people
were at higher risk of MetS in this study. Evidence exists that
better nutritional status is associated with higher socioeconomic
status [16,42–43]. We also found a significant correlation between
asset index and nutritional status (r=0.149) (p=0.002) in our
study population. It was not possible to find the causal direction of
relationships of asset index, well nourishment, and MetS, but the
study confirms the positive associations of more wealth and well
nourishment with the risk of MetS. More studies are warranted to
explore a causal relationship of higher prevalence of MetS and
better socio-economic status.
Table 3. Prevalence of the metabolic syndrome by age and gender.
Men Women Total
Age group, years N n Prevalence (%) N n
Prevalence
(%) N n
Prevalence
(%)
60–64 60 12 32.4 79 15 28.8 139 27 30.3
65–69 65 11 29.7 69 18 34.6 134 29 32.6
70–74 41 7 18.9 43 8 15.4 84 15 16.9
$75 40 7 18.9 59 11 21.2 99 18 20.2
Total 206 37 18.0 250 52 20.8 456 89 19.5
doi:10.1371/journal.pone.0020259.t003
Table 4. Unadjusted and adjusted odds ratios (OR) and 95%
confidence intervals (CI) of Metabolic Syndrome: Results from
logistic regression analyses.
Metabolic syndrome
Unadjusted OR (95%
CI) Adjusted OR (95% CI)
a
Age group, years
60–69 1.00 (Ref) 1.00 (Ref)
70+ 0.85 (0.53–1.38) 0.84 (0.48–1.46)
Sex
Men 1.00 (Ref.) 1.00 (Ref.)
Women 1.20 (0.75–1.92) 0.90 (0.32–2.53)
Literacy*
Illiterate 1.00 (Ref.) 1.00 (Ref.)
Literate 1.32 (0.83–2.11) 1.09 (0.61–1.95)
Marital Status*
Single 1.00 (Ref.) 1.00 (Ref.)
Married 0.99 (0.62–1.59) 0.96 (0.47–1.97)
Asset index
#
Lowest tertile 1.0 (Ref.) 1.00 (Ref.)
Middle tertile 3.16 (1.62–6.14) 2.95 (1.41–6.15)
Highest tertile 2.74 (1.40–5.38) 2.78 (1.31–5.89)
Smoking
No 1.00 (Ref.) 1.00 (Ref.)
Yes 0.67 (0.41–1.09) 0.58 (0.23–1.46)
Tobacco leaf
No 1.00 (Ref.) 1.0 (Ref.)
Yes 0.68 (0.42–1.12) 0.81 (0.47–1.42)
Nutritional status1
Not well-nourished 1.0 (Ref.) 1.0 (Ref.)
Well-nourished 3.44 (1.88–6.29) 3.05 (1.58–5.90)
OR=odds ratio; CI=confidence interval.
*Data on literacy and marital status were missing for 3 participants.
#Data on asset index was missing for 24 persons.
1Data on Nutritional status was missing for 13 persons.
aORs (95% CIs) were derived from the model that included age, sex, literacy,
marital status, asset index, smoking, tobacco leaf and nutritional status.
doi:10.1371/journal.pone.0020259.t004
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examine the association of independent variables (age, sex,
literacy, marital status, smoking, use of tobacco leaf, nutrition
and asset index) with each component of the MetS. Among the
variables studied, association of age with hypertension and
triglyceride was in opposite direction. The risk of high blood
pressure is associated with higher age, whereas risk is reduced with
higher age for high triglyceride. The overall association of
nutrition and asset index with metabolic syndrome was mostly
due to their association with high triglyceride and high BMI.
Overall, MetS was not associated with 5-year survival, although
our analysis suggests a potential impact of MetS on poor survival
among individuals with high RBG. Due to small sample size and
relatively short follow up time the study lacks power to show
significant difference in survival rates.
Further analyses were performed to explore if the results differ
with changing the cutoff of components. We didn’t find any
difference in results. The prevalence of MetS ranged between 14.5
ceteris paribus, changing the cutoff for blood pressure from
$130 mm Hg to $140 mm Hg and 22.8 ceteris paribus, changing
the cutoff for TG from $2.28 to $1.7 mmol/L. Nutrition and
asset index remained statistically significant as before. The
association of well nourishment with metabolic syndrome
remained significant with a variation of odds ratio from 2.02 to
4.49 when changing the cutoffs of different components. Only
when we change the cutoff for blood pressure from $130 mm Hg
to $140 mm Hg, the wealthiest tertile become insignificant.
Survival rates ranged between 75% to 79.4%.
Several limitations of the study should be mentioned. The cross-
sectional design requires that caution should be taken before
making causal interpretations on the basis of the findings. Waist
circumference was not available, instead we used BMI as a proxy
for abdominal adiposity in conformity with other studies that have
used BMI to replace waist circumference [9,44–48]. Although
measurements were based on non-fasting blood samples, which
particularly affects triglyceride and glucose levels, other studies
using non fasting measurement have found the predictivity for
CHD comparable to studies that have used fasting measurements
Figure 1. Survival curve of the elderly people by metabolic syndrome, up to 5 years.
doi:10.1371/journal.pone.0020259.g001
Figure 2. Five-years survival related to MetS by different components of MetS. (* p,0.05). RBG=Random Blood Glucose, TG=Triglyceride,
BMI=Boby Mass Index.
doi:10.1371/journal.pone.0020259.g002
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30% higher than fasting levels. We have used a cut-off $200 mg/
dL ($2.28 mmol/L) to define high triglyceride, which is in line
with other relevant studies [18]. The WHO criteria for diagnosis
of the MetS is more complex because it takes into consideration
microalbuminuria, plasma insulin level. NCEP definition of
metabolic syndrome does not specify that any particular
component be present. The NCEP criteria imply that if one has
many risk factors, even if they are not very severe, their joint
contribution can still markedly increase the risk of CHD.
Murray and Lopez (1996) predicted that CVD will increase in
low- and middle-income countries, and that it will be the leading
cause of death and disability worldwide by 2020 [49]. The
economic and social costs of this burden will be great, particularly
because many developing nations are still grappling with poverty-
related diseases such as malnutrition, infectious diseases, and poor
health care facilities. It is desirable to identify the warning signs of
the MetS, thereby facilitating early education and intervention
among these individuals. Additional prospective long-term studies
are required to identify the combination of components of the
MetS that identify more precisely persons who will develop type 2
diabetes and/or cardiovascular morbidity. Our findings highlight
the importance of MetS and may be useful for designing future
preventive actions against diabetes and cardiovascular diseases.
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